-
Signature
-
/s/ Andrew Polovin, Attorney-in-Fact
-
Issuer symbol
-
TEM
-
Transactions as of
-
20 May 2025
-
Net transactions value
-
-$1,462,809
-
Form type
-
4
-
Filing time
-
22 May 2025, 20:00:15 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Rogers James William |
Chief Financial Officer |
C/O TEMPUS AI, INC., 600 WEST CHICAGO AVENUE, SUITE 510, CHICAGO |
/s/ Andrew Polovin, Attorney-in-Fact |
22 May 2025 |
0002024630 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TEM |
Class A Common Stock |
Sale |
$720,404 |
-11,397 |
-6.7% |
$63.21 |
157,725 |
20 May 2025 |
Direct |
F1, F2 |
| transaction |
TEM |
Class A Common Stock |
Sale |
$1,019 |
-16 |
-0.01% |
$63.70 |
157,709 |
20 May 2025 |
Direct |
F1 |
| transaction |
TEM |
Class A Common Stock |
Sale |
$223,416 |
-3,600 |
-2.3% |
$62.06 |
154,109 |
20 May 2025 |
Direct |
F3, F4 |
| transaction |
TEM |
Class A Common Stock |
Sale |
$94,856 |
-1,509 |
-0.98% |
$62.86 |
152,600 |
20 May 2025 |
Direct |
F3, F5 |
| transaction |
TEM |
Class A Common Stock |
Sale |
$370,730 |
-5,799 |
-3.8% |
$63.93 |
146,801 |
20 May 2025 |
Direct |
F3, F6 |
| transaction |
TEM |
Class A Common Stock |
Sale |
$19,434 |
-300 |
-0.2% |
$64.78 |
146,501 |
20 May 2025 |
Direct |
F3, F7 |
| transaction |
TEM |
Class A Common Stock |
Sale |
$32,950 |
-500 |
-0.34% |
$65.90 |
146,001 |
20 May 2025 |
Direct |
F3, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: